[ref] Talk with your doctor or pharmacist if you are on prescription medications to see if there is any interaction with any new supplement before you start it
The safety and effectiveness can vary depending on the individuals health and genetics
Yes, regulatory agencies continuously review the safety profile of semaglutide and update the medical community and public on any new safety information
[24] [25] Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, has been approved for type 2 diabetes in the UK and shows even greater efficacy for both glucose control and weight loss
Against that, it notes some patients do better on ongoing or periodic therapy, particularly if regain has historically been rapid or if conditions such as prediabetes or hypertension improved substantially on treatment
Dermatologic: rash, erythema, pruritus CNS: headache, dizziness, agitation, anxiety Ophthalmic: diplopia 7